ad

Nureca Ltd. (NURECA) Share Price Trades Within 2% of 52-Week High

13 Aug 202610:40 am

Nureca Ltd. (NURECA) Share Price Trades Within 2% of 52-Week High

Nureca Ltd. Share Price stood at Rs 349 at 10:31 AM IST, with the stock trading within 2% of its 52-week high. Market capitalisation was Rs 303.58 crore.

Nureca Ltd. Share Price was at Rs 349 at 10:31 AM IST on 13 August 2026, and the stock was trading within 2% of its 52-week high. With a market capitalisation of Rs 303.58 crore, the move puts the small-cap healthcare name on the radar for investors tracking fresh strength near one-year peak levels.

The verified data used by Univest confirms the price event and shows that Nureca Ltd. Share Price has moved close enough to its yearly high to qualify on the screener. That matters because stocks near their 52-week highs often attract added market attention for two reasons: they can reflect sustained momentum, and they can trigger a closer review of valuation, profitability and peer positioning.

At the same time, the supplied data does not establish a company-specific catalyst behind the move. What it does show is that Nureca Ltd. Share Price is being watched in the context of a healthcare business operating in the Medical Equipment/Supplies/Accessories industry, where its profitability metrics stand out against several benchmark figures. That makes the current setup relevant not just as price action, but also as a broader stock analysis case for investors following Nureca Ltd. Stock News on Univest.

Nureca Ltd. Share Price Today: Within 2% of 52-Week High

Metric Value
LTP at 2% Qualification Rs 349
Market Capitalisation Rs 303.58 crore
52-Week High Position Trading within 2% of its 52-week high

Nureca Ltd. (NURECA) traded at Rs 349. Reported volume was 237.

Nureca Ltd. Share Price Today was Rs 349 at the time the Univest screener identified the stock as trading within 2% of its 52-week high. The event timestamp was 13 August 2026 at 10:31:00 AM IST, which gives a precise reference point for the move being discussed. In practical terms, that means Nureca Ltd. Share Price was trading in a zone that often draws heightened trader and investor attention, even without confirming a breakout or a fresh record.

When a stock remains close to its one-year high, market participants typically read that as a sign that demand has been resilient enough to keep prices elevated relative to the past 12 months. That does not, by itself, say anything about what happens next. However, it does make Nureca Ltd. Share Price Today more relevant for anyone studying current market leadership, relative strength and how smaller healthcare names are being valued.

For this event, the strongest verified takeaway is straightforward: Nureca Ltd. Share Price is in a price zone that many investors monitor closely because it can coincide with improving sentiment, stronger relative positioning within its industry and renewed attention to business quality. Since the supplied dataset also includes profitability and valuation measures, the next step is to test whether the underlying fundamentals add support to the market’s interest in Nureca Ltd. Share Price.

Nureca Ltd. (NURECA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 303.58 crore
P/E Ratio 73.5x
P/B Ratio 1.73x
ROE 24.55%
ROCE 33.57%
EPS Rs 4.55
Book Value Per Share Rs 192.65
Dividend Yield 0%

Nureca Ltd. was valued at a P/E ratio of 73.5x, a P/B ratio of 1.73x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 24.55% and ROCE of 33.57%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 4.55, book value per share of Rs 192.65, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Medical Equipment/Supplies/Accessories
Benchmark Scope same industry
Company P/E Ratio 73.5x
Benchmark Median P/E 24.46x
Benchmark Average P/E 31.21x
Benchmark P/E Range 0x to 99.65x
Company P/B Ratio 1.73x
Benchmark Median P/B 3.52x
Company ROE 24.55%
Benchmark Median ROE 13.84%
Company ROCE 33.57%
Benchmark Median ROCE 16.76%
Company Market Capitalisation Rs 303.58 crore
Benchmark Median Market Cap Rs 110.37 crore

Nureca Ltd. (NURECA) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

Nureca Ltd. (NURECA) has a P/E ratio of 73.5x, which is above the benchmark median of 24.46x, a difference of +200.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Nureca Ltd. (NURECA) has a ROE of 24.55%, which is above the benchmark median of 13.84%, a difference of +77.38%. Nureca Ltd. (NURECA) has a ROCE of 33.57%, which is above the benchmark median of 16.76%, a difference of +100.3%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Yash Optics & Lens Ltd. YASHOPTICS-SM 282.33 31.2 3.12 24.92 19.68
Prevest Denpro Ltd. PREVEST 455.75 20.58 3.53 38.13 46.96
Earkart Ltd. EARKART 192.49 39.03 2.99 2.22 2.34
Hemant Surgical Industries Ltd. HSIL 526.26 28.56 3.61 13.84 14.34
AVIENCE BIOMEDICALS LTD AVIENCE-SM 136.03 15.72 5.68 20.63 20.56

Nureca Ltd. (NURECA) has a P/E ratio of 73.5x compared with the displayed peer median of 28.56x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 24.55% compares with a peer median of 20.63% across the companies shown in the table. ROCE stood at 33.57% versus the displayed peer median of 19.68%, providing a capital-efficiency comparison. Nureca Ltd. (NURECA) has a market capitalisation of Rs 303.58 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Nureca Ltd.

  • Nureca Ltd. Share Price was Rs 349 at the screener trigger and was trading within 2% of its 52-week high.
  • Market capitalisation stands at Rs 303.58 crore, placing the stock in the small-cap healthcare space.
  • P/E is 73.5, above same-industry median and average levels, showing a premium earnings valuation.
  • P/B is 1.73, below the same-industry median of 3.52 and average of 3.52.
  • ROE of 24.55% and ROCE of 33.57% are above the industry median benchmarks.
  • Peer data shows Nureca carries a richer P/E than several comparables, but a lower P/B than all five listed peers supplied.

About Nureca Ltd.

Nureca Ltd. operates in the Healthcare sector and is classified under the Medical Equipment/Supplies/Accessories industry. Based on the supplied classification data, the company is part of a business segment that serves healthcare-related equipment and supply demand, placing it alongside listed medical device, diagnostic and healthcare-product peers tracked by Univest.

From an investor-tracking perspective, that industry positioning is important because it shapes how Nureca Ltd. Share Price is compared on valuation, return ratios and market size. The company’s relevant listed peer set includes smaller and mid-sized names in medical equipment and accessories, and the same-industry benchmark used here covers 19 companies. That gives a focused context for reading P/E, P/B, ROE and ROCE rather than comparing the business with unrelated healthcare segments. For readers following Nureca Ltd. Stock News, the key point is that the company sits in a niche where profitability and valuation can differ sharply across peers, making direct industry comparison especially useful.

Track Nureca Ltd. Share Price on Univest

Use Nureca Ltd. (NURECA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers tracking Nureca Ltd. Share Price can use Univest to follow live price moves, 52-week levels, valuation ratios, profitability indicators, peer comparisons and broader market insights in one place. Univest also helps users monitor how Nureca Ltd. Share Price Today compares with industry benchmarks, making it easier to place short-term price action within a deeper fundamental and sector framework.

For investors who regularly track Nureca Ltd. Stock News, Univest offers a structured way to review the share price alongside P/E, P/B, ROE, ROCE, market capitalisation and peer data. That is especially relevant when Nureca Ltd. Share Price is trading close to a one-year high and market attention is increasing around the stock.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is Nureca Ltd. Share Price today?

Ans. Nureca Ltd. Share Price was Rs 349 at 10:31 AM IST on 13 August 2026, when the Univest screener flagged the stock. At that point, it was trading within 2% of its 52-week high.

Why is Nureca Ltd. Share Price in focus today?

Ans. Nureca Ltd. Share Price is in focus because the stock was trading within 2% of its 52-week high. Such positioning often attracts attention to momentum, valuation and industry-relative performance, especially in smaller healthcare stocks.

What is the market capitalisation of Nureca Ltd.?

Ans. Nureca Ltd. had a market capitalisation of Rs 303.58 crore in the supplied data. That places it above the same-industry median market cap of Rs 110.37 crore, but below the industry average of Rs 328.03 crore.

Is Nureca Ltd. Share Price expensive on valuation?

Ans. On earnings valuation, Nureca Ltd. Share Price looks rich because its P/E ratio is 73.5, above the same-industry median of 24.46 and average of 31.21. However, its P/B ratio of 1.73 is below both industry benchmarks.

How profitable is Nureca Ltd. compared with its industry?

Ans. Nureca Ltd. reported ROE of 24.55% and ROCE of 33.57%. Both are above the same-industry median levels of 13.84% and 16.76%, and also above the corresponding industry averages of 23.31% and 24.69%.

How does Nureca Ltd. compare with listed peers?

Ans. Nureca Ltd. has a higher P/E ratio than supplied peers such as Prevest Denpro, Yash Optics & Lens and Hemant Surgical Industries. Its P/B ratio of 1.73, however, is lower than all five peers in the dataset.

Which sector and industry does Nureca Ltd. belong to?

Ans. Nureca Ltd. belongs to the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The supplied industry benchmark covers 19 companies, giving investors a focused base for comparing valuation, profitability and market-cap positioning.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down